Dear NGS users/developers,

please consider sending your work on NGS methods and applications to 
the 5th Hitseq meeting. This year it is going to be in Long Beach, CA.

Please find the (last) call for abstracts below.

Cheers, Gunnar

HiTSeq 2012:  Conference on High Throughput Sequencing Methods and Applications

July 13-14, 2012 in Long Beach, CA, USA

Last Call for Abstracts (Deadline Extended)

Key Dates:
*       June 1st – Abstract submission deadline (EXTENDED)
*       June 8th – Oral/Poster Presentation Decisions
*       June 30th – Late breaking poster deadline
*       July 13-14 - Conference

The Conference on High Throughput Sequencing Methods and Applications 
(HiTSeq 2012) is a Satellite of the ISMB 2012 conference and brings 
together biologists and computational scientists interested in 
exploring the challenges and opportunities in the analysis of high-
throughput sequencing (HTS) technologies. HiTSeq 2012 welcomes 
submissions on any topic related to high throughput sequencing 
technologies. We are especially interested in presentations describing 
methodology to infer various genetic variants (SNVs, small and larger 
insertions/deletions, copy number variants), methods for analysis of 
RNA sequencing data (RNA expression, de-novo transcriptome sequencing, 
novel transcript discovery), and other applications of HTS 
(transcription factor binding site discovery, methylation profiling, 
cancer somatic aberration analysis, genome-wide disease association 
studies by HTS, metagenomics). We are also interested in algorithms 
for compressing and handling effectively large amounts of HTS data, 
and the analysis of data from the emerging 3rd and 4th generation 
sequencing platforms.

* Dr. Chris Sander. Chair, Computational Biology Program, Memorial Sloan 
Kettering Cancer Center.
* Dr. Stan Nelson. UCLA Jonsson Comprehensive Cancer Center.

New: Special track on “Personal Genomes for Individualized Medicine”

There is currently a surge in the sequencing of “personal” genomes (or 
exomes) with the intent of applying them in clinical decision-making. 
>From the diagnosis of Mendelian and idiopathic diseases, the 
identification of somatic mutations in cancer tumors to guide therapy 
selection, to the prediction of susceptibility to complex disease to 
enable prophylactic actions, the applications of personal genomes 
herald an imminent change in how clinicians use genetic information in 
individualized medicine.  Nevertheless, an analysis bottleneck is 
becoming apparent, and thus algorithms, methods, visualizations, and 
efficient software to handle the onslaught of medical genomic 
information are badly needed. 

In this special track of HiTSeq 2012 we aim to showcase the methods 
and tools that academic and industry researchers are developing in 
this area, and to encourage a vigorous discussion of what is needed to 
go forward. We are seeking paper and abstract submissions with an 
emphasis on analysis methods for the case when the sample size is n=1 
(i.e. the patient), how to make genome sequence analysis efficient & 
clinical grade, as well as new techniques to summarize the wealth of 
genomic information for clinical decision-making. Applications ranging 
childhood diseases, cancer treatment, and complex disease 
susceptibility are all welcome. This special track session will be 
held on the second day of the SIG (July 14).

Simultaneously, HiTSeq also allows for submission of abstracts, which 
will be evaluated independently for the meeting proceedings. The 
abstracts should target topics of immediate relevance in the field. To 
be considered for an oral presentation the material should not have 
been previously published in any journal or proceedings. Late breaking 
poster abstracts will be also accepted for exceptional research 
results that became available after the other deadlines. Please check 
the conference website for submission instructions. 

Oral/Poster presentations:
Presentations at HiTSeq may be either plenary talks or a poster at the 
meeting’s poster session. The final decisions whether each paper or 
abstract is presented as a talk or a poster will be made by May 30.

Gunnar Rätsch, Sloan-Kettering Institute, USA
Francisco M. De La Vega, Stanford University, USA
Inanc Birol, British Columbia Cancer Agency, Canada
Sohrab Shah, British Columbia Cancer Agency, Canada

Questions?  Contact e-mail:

Dr. Gunnar Rätsch
Associate Professor and Lab Head
Computational Biology Center               
Memorial Sloan-Kettering Cancer Center

Office address:
415-417 E 68th street, Room Z-690
New York, NY 10065, USA

Postal address:
1275 York Avenue, Box 357
New York, NY 10065, USA
p: +1 646 888 2802
f: +1 646 888 3105

     Please note that this e-mail and any files transmitted from
     Memorial Sloan-Kettering Cancer Center may be privileged, confidential,
     and protected from disclosure under applicable law. If the reader of
     this message is not the intended recipient, or an employee or agent
     responsible for delivering this message to the intended recipient,
     you are hereby notified that any reading, dissemination, distribution, 
     copying, or other use of this communication or any of its attachments
     is strictly prohibited.  If you have received this communication in 
     error, please notify the sender immediately by replying to this message
     and deleting this message, any attachments, and all copies and backups
     from your computer.

The Galaxy User list should be used for the discussion of
Galaxy analysis and other features on the public server
at  Please keep all replies on the list by
using "reply all" in your mail client.  For discussion of
local Galaxy instances and the Galaxy source code, please
use the Galaxy Development list:

To manage your subscriptions to this and other Galaxy lists,
please use the interface at:

Reply via email to